Gastrointestinal toxicities associated with immune checkpoint inhibitors: a disproportionality analysis leveraging VigiBase, the WHO Adverse Drug Reaction Database

Documenti analoghi

• Mapping endocrine toxicity spectrum of immune checkpoint inhibitors: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase
  di: Bai, Xuefeng, et al.
  Pubblicazione: (2020)
• Adverse Event Reporting with Immune Checkpoint Inhibitors in Older Patients: Age Subgroup Disproportionality Analysis in VigiBase
  di: Noseda, Roberta, et al.
  Pubblicazione: (2021)
• Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase
  di: Alessandro Ceschi, et al.
  Pubblicazione: (2024-11-01)
• Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase
  di: Mahé, Julien, et al.
  Pubblicazione: (2018)
• Cardiovascular Safety of COVID-19 Treatments: A Disproportionality Analysis of Adverse Event Reports from the WHO VigiBase
  di: Hoi K. Cheng, et al.
  Pubblicazione: (2025-09-01)